SCHEMBL30775055

SCHEMBL30775055

Cc1ccc(-c2ccccn2)c(C(=O)O)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
KMT2A Q03164 1/20 0.48
GRM5 P41594 3/20 0.45
KDM6B O15054 1/20 0.44
KDM4A O75164 1/20 0.44
KDM5C P41229 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
KDM2A Q9Y2K7 1/20 0.44
KDM3A Q9Y4C1 1/20 0.44
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HCRTR1 O43613 3/20 0.42
HCRTR2 O43614 1/20 0.42
IKBKB O14920 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PIN1 Q13526 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385678 1.00 KDM4E (0.48) KDM4EKMT2AGRM5KDM6BKDM4A
SCHEMBL30761191 0.86 IKBKB (0.49) KDM4EKMT2AGRM5NPC1TP53
SCHEMBL20773709 0.84 L3MBTL1 (0.46) KDM4EGRM5NPC1TP53HPGD
SCHEMBL30775039 0.84 L3MBTL1 (0.46) KDM4EGRM5NPC1TP53HPGD
SCHEMBL6342333 0.83 LMNA (0.50) KDM4EKMT2AKDM6BKDM4AKDM5C
SCHEMBL264270 0.82 HCRTR2 (0.50) KDM4EHCRTR1HCRTR2ALDH1A1L3MBTL1
SCHEMBL30775045 0.82 HCRTR2 (0.50) KDM4EHCRTR1HCRTR2ALDH1A1L3MBTL1
SCHEMBL7911678 0.82 CCR1 (0.50) KDM4EGRM5HPGDRAB9AALDH1A1
Lithium SCHEMBL607039 0.81 HCRTR2 (0.49) KDM4EHCRTR1HCRTR2ALDH1A1L3MBTL1
SCHEMBL3389125 0.81 KDM4E (0.49) KDM4EHCRTR1HCRTR2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688155-A1 MORPHOLINE OREXIN RECEPTOR ANTAGONISTS Bial-Portela & CA, S.A. (PT) 2026-02-11 EP disclosed
WO-2025023852-A1 MORPHOLINE OREXIN RECEPTOR ANTAGONISTS BIAL - PORTELA & CA., S.A. (PT) 2025-01-30 WO disclosed
CN-111315734-B Substituted 2-azabicyclo [3.1.1] heptane and 2-azabicyclo [3.2.1] octane derivatives as orexin receptor antagonists 克罗诺斯治疗有限公司 2024-03-08 CN disclosed